An hypochlorous acid-responsive NIR-IIb nanosensor for In Vivo monitoring of inflammatory bowel disease progression

Key Points

• In vivo monitoring of inflammatory bowel disease progression demonstrates high sensitivity with a nanosensor.
• The nanosensor utilizes hypochlorous acid detection capabilities, achieving substantial accuracy in tracking disease markers.
• Assessment using a nanosensor technology highlights the role of biomarkers in real-time analysis of inflammation.
• Potential impact if successful includes improved management strategies for patients with inflammatory bowel disease.